Copertina

ECT2 is a sensitive and specific marker of transformation in the human breast.

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Mamoor, Shahan
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

ECT2 is a sensitive and specific marker of transformation in the human breast.
di: Mamoor, Shahan
Pubblicazione: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Activation of ZIC family genes in CNS metastasis in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Gasdermin activation during lineage specification in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

SSX2IP induction in basal subtype breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
di: Mamoor, Shahan
Pubblicazione: (2026)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
di: Mamoor, Shahan
Pubblicazione: (2026)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
di: Mamoor, Shahan
Pubblicazione: (2025)

Developmental stage-specific control of proliferation and senescence by EZH2.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: MAP2K3.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
di: Mamoor, Shahan
Pubblicazione: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Phosphatase targeting in Luminal B breast cancer: PGP.
di: Mamoor, Shahan
Pubblicazione: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
di: Mamoor, Shahan
Pubblicazione: (2025)

Kinase targeting in Luminal B breast cancer: DTYMK.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
di: Mamoor, Shahan
Pubblicazione: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
di: Mamoor, Shahan
Pubblicazione: (2025)